Outcome of Treating Bladder Cancer in Sohag University Hospital
NCT05082818 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 168
Last updated 2022-06-14
Summary
Retrospective study of outcome of urinary bladder cancer treated in Sohag University hospital in the past 5 years from 2016 to 2020
Conditions
Interventions
- COMBINATION_PRODUCT
-
Chemotherapy, Radiotherapy and surgery
Trans urethral resection of the tumour or radical cystectomy
Sponsors & Collaborators
-
Sohag University
lead OTHER
Principal Investigators
-
Samah Refaat · Sohag University
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-30
- Primary Completion
- 2022-05-28
- Completion
- 2022-05-30
Countries
- Egypt
Study Locations
More Related Trials
-
Autophagy Bladder Cancer
NCT03254888 ·Status: UNKNOWN
-
Safety and Efficacy of Scheduled Intravesical Gemcitabine Versus Intravesical BCG for Intermediate and High Risk Non Muscle Invasive Bladder Cancer: A Prospective, Randomized Study
NCT05626101 ·Status: RECRUITING ·Phase: NA
-
A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)
NCT03121768 ·Status: UNKNOWN
-
Oncological Outcomes of Different Patterns of Tumor Recurrence at First Evaluation After Bacillus Calmette-Guérin Induction Therapy for Intermediate and High Risk Non Muscle Invasive Bladder Cancer
NCT04319263 ·Status: COMPLETED ·Phase: NA
-
Basal Tumours in Bladder Cancer, Response to chemoTherapy
NCT04089748 ·Status: COMPLETED
-
Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
NCT06350734 ·Status: ACTIVE_NOT_RECRUITING
-
Adjuvant Intraarterial Chemotherapy Following Surgery to Treat Locally Advanced Bladder Cancer
NCT01627197 ·Status: COMPLETED ·Phase: PHASE3
-
Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder Cancer
NCT02716961 ·Status: UNKNOWN ·Phase: NA
-
Skipping BCG for T1a Urinary Bladder Tumor.
NCT04298073 ·Status: UNKNOWN
-
Adjuvant Chemotherapy Following Radical Cystectomy to Treat Locally Advanced Bladder Cancer
NCT02074189 ·Status: UNKNOWN ·Phase: PHASE3
-
Immunohistochemical Expression of CXCL5 as a Valuable Prognostic Marker in Urinary Bladder Urothelial Carcinoma
NCT05139134 ·Status: UNKNOWN
-
Adjuvant Radiotherapy Versus Observation After Radical Cystectomy in High Risk Urothelial Bladder Cancer
NCT04740866 ·Status: UNKNOWN ·Phase: NA
-
Histopathological Findings in En-Bloc vs Conventional Transurethral Resection of Bladder Tumors.
NCT07259798 ·Status: COMPLETED ·Phase: NA
-
Radical Cystectomy Versus Tri-Modal Therapy for Treatment of cT2N0M0 Urinary Bladder Transitional Cell Carcinoma
NCT07043790 ·Status: COMPLETED ·Phase: NA
-
Outcome of Radiation Therapy in Urinary Bladder Squampus Cell Carcinoma
NCT04815629 ·Status: UNKNOWN
-
Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments
NCT06138561 ·Status: RECRUITING
-
Assessment Of Bladder Tumors Stage And Grade By Outpatient Flexible Cystoscopy Performed By Urology Resident
NCT03148158 ·Status: UNKNOWN
-
Prognostic Biomarkers in Patients With Urothelial Carcinoma
NCT04872036 ·Status: COMPLETED
-
Sequential Combination Therapy in Bladder Cancer
NCT03790384 ·Status: UNKNOWN ·Phase: PHASE4
-
Carboplatin-gemcitabine Versus Cisplatin- Gemcitabine as Neoadjuvant Chemotherapy for Treatment of Muscle Invasive Urinary Bladder Cancer
NCT05822934 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder Cancer
NCT02214602 ·Status: COMPLETED ·Phase: PHASE4
-
SHR-1501 Combined With SHR-2005 for High-Risk Non-Muscle Invasive Bladder Cancer Which is Not Completely Resectable by TURBt
NCT06588179 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and Progression
NCT02443844 ·Status: UNKNOWN ·Phase: PHASE4
-
Malignant Genito-urinary Tumors in Children: South Egypt Cancer Institute Experience
NCT02557230 ·Status: UNKNOWN
-
Sensitivity of Multiparametric MRI in Differentiation Between Muscle Invasive and Non-muscle Invasive Urinary Bladder Cancer
NCT05324033 ·Status: COMPLETED